ANI Pharmaceuticals, Inc. Sustainability Profile
ANI Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded prescription medications. With a focus on complex formulations, ANI Pharmaceuticals serves a diverse range of therapeutic areas, including pain management, oncology, and anti-infectives. The company’s commitment to innovation is evident in its extensive portfolio of products, which includes unique formulations that address unmet medical needs. ANI Pharmaceuticals has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint across major regions in the US. With a strong market position and a dedication to quality, ANI Pharmaceuticals continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does ANI Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ANI Pharmaceuticals, Inc.'s score of 25 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ANI Pharmaceuticals, Inc.'s reported carbon emissions
ANI Pharmaceuticals, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific figures. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing greenhouse gas emissions at this time. As there are no emissions data or reduction initiatives reported, ANI Pharmaceuticals, Inc. appears to be in the early stages of addressing climate-related issues within its operations. The absence of emissions data and reduction targets may reflect a broader trend in the pharmaceutical industry, where companies are increasingly being called upon to disclose their environmental impact and set ambitious climate goals. In summary, ANI Pharmaceuticals, Inc. has not yet provided specific emissions data or climate commitments, indicating an opportunity for the company to enhance its sustainability efforts and align with industry standards for climate action.
How Carbon Intensive is ANI Pharmaceuticals, Inc.'s Industry?
How Carbon Intensive is ANI Pharmaceuticals, Inc.'s Location?
ANI Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ANI Pharmaceuticals, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
